Sinovac Biotech (SVA) Reports Q2 Loss of $0.17
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Sinovac Biotech (NASDAQ: SVA) reported Q2 EPS of ($0.17), versus $0.04 reported last year. Revenue for the quarter came in at $1.38 billion, versus $18.49 billion reported last year.
For earnings history and earnings-related data on Sinovac Biotech (SVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- lululemon athletica (LULU) Tops Q3 EPS by 4c; Adj.-Comps Outpaced Views
- Ciena (CIEN) Misses Q4 EPS by 2c
- Science Applications Int'l (SAIC) Tops Q3 EPS by 7c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!